Welcome to European Tribune. It's gone a bit quiet around here these days, but it's still going.
Science, A prominent virologist warns COVID-19 pill could unleash dangerous mutants. Others see little cause for alarm, 7 Nov
Molnupiravir, which Merck and Ridgeback Biotherapeutics developed from an earlier, experimental antiviral, works by interfering with viral replication, littering the viral genome with mutations until the virus can no longer reproduce.... The drug's ability to mutate RNA has raised persistent fears that it could induce mutations in a patient's own genetic material, possibly causing cancer or birth defects; studies so far have not borne out those fears.
On 30 November, a Food and Drug Administration advisory committee will review possible emergency use authorization for molnupiravir in the United States.
archived Miracle in Japan, [EMA] EU says Merck's [molnupiravir] pill can be taken in emergencies, FDA advisers narrowly endorse Merck's Covid-19 drug, molnupiravir 13-10 PF-07321332
by Cat on Sat Dec 4th, 2021 at 01:15:51 AM EST
[ Parent ]

Others have rated this comment as follows:


Top Diaries

Occasional Series